Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperinsulinemic euglycaemia after myocardial infarction
ACTRN12617000845336Phase 2Recruiting
- Sponsor
- Sunshine Coast University Hospital
- Start
- Oct 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of human insulin and glucose in myocardial infarction (MI) (2 arms), sponsored by Sunshine Coast University Hospital. Primary endpoint: Perfusion defect size. Started Oct 2016; status: recruiting.
02
Drugs
human insulinglucose
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ACTRN12617000845336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000845336.